Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11901
Quantum Dot Hybridization of Piezoelectric Polymer Films for Non-Transfer Integration of Flexible Biomechanical Energy Harvesters
Published 2022“…Their specific output voltage and charge density were stably maintained at 7.16 V and 2.40 nC/cm<sup>2</sup>, which were 30.7 and 50.0% higher than those of FPENGs based on a pure piezoelectric polymer film, respectively. …”
-
11902
Quantum Dot Hybridization of Piezoelectric Polymer Films for Non-Transfer Integration of Flexible Biomechanical Energy Harvesters
Published 2022“…Their specific output voltage and charge density were stably maintained at 7.16 V and 2.40 nC/cm<sup>2</sup>, which were 30.7 and 50.0% higher than those of FPENGs based on a pure piezoelectric polymer film, respectively. …”
-
11903
Presentation_1_Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study.PPTX
Published 2022“…Surprisingly, patients’ RBC-iROS were decreased, a finding possibly related with the increased G6PDH levels in this group, suggesting a possible compensatory mechanism against the virus. …”
-
11904
Supplementary Material for: GLPG2737, a CFTR Inhibitor, Prevents Cyst Growth in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease
Published 2025“…Results: GLPG2737 inhibited chloride flux in mIMCD-3 cells with an IC50 of 2.41 µM. In a 3D assay, GLPG2737 inhibited cyst growth in both wild-type (IC50 = 2.36 µM) and Pkd1 knockout (IC50 = 2.5 µM) mIMCD-3 cells. …”
-
11905
<i>In Vitro</i> and <i>In Vivo</i> Antifungal Activity of Lichochalcone-A against <i>Candida albicans</i> Biofilms - Fig 5
Published 2016“…<i>albicans</i> enzymes secretion expressed in U/grams of dry weight after treatment with lichochalcone-A at concentrations of 625 μM and 1500 μM: <b>A.…”
-
11906
The amplitude of AMPA-mEPSC is suppressed in Tmub1/HOPS-RNAi neurons in a GluR2-containing AMPAR dependent manner.
Published 2008“…<p>(A) Representative traces of AMPAR-mediated mEPSC. …”
-
11907
-
11908
-
11909
-
11910
-
11911
-
11912
-
11913
-
11914
-
11915
-
11916
Supplementary Material for: Vitamin D status and treatment in ESKD; links to improved CKD-MBD laboratory parameters in a real-world setting
Published 2024“…Laboratory parameters were measured every 6 (phosphate, calcium) or 12 weeks (25(OH)D3, PTH, ALP) until February, 2021. In September, 2018 a treatment algorithm of 50,000 IU weekly until sufficient, followed by 50,000 IU monthly was suggested. …”
-
11917
Self-paced combined training alleviated oxidative stress, inflammatory responses and hyperlipidaemia in people living with multiple sclerosis: a randomised controlled trial
Published 2024“…</p> <p><b>Results:</b> Comparatively with CG, the TG showed a decrease in advanced oxidation protein products (p = 0.002, Hedges’g (g) = 1.50) and total thiols (p = 0.0011, g = 1.57), as well as an increase in reduced glutathione (p = 0.03, g = 0.98). …”
-
11918
Items.
Published 2023“…<div><p>Epilepsy is a common, serious condition. Fortunately, seizure risk decreases with increasing seizure-free time on antiseizure medications (ASMs). …”
-
11919
Survey feedback.
Published 2023“…<div><p>Epilepsy is a common, serious condition. Fortunately, seizure risk decreases with increasing seizure-free time on antiseizure medications (ASMs). …”
-
11920
DataSheet_1_A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor ac...
Published 2023“…Background<p>QL1604 is a humanized immunoglobulin G4 monoclonal antibody against programmed cell death protein 1. …”